News

CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates Entered into ...
Pfizer's inclacumab fails Phase III study for sickle cell disease, disappointing the community while the company remains ...
Eli Lilly will raise UK list prices for its Mounjaro weight-loss jab by as much as 170% from September after Donald Trump ...
Researchers from MIT have used generative AI (genAI) algorithms to design novel antibiotics that can treat two 'superbugs' – ...
Daniel Snell, CEO of Arrival, shares advice on how employees can prove their efficiency at work amidst the AI revolution.
AbbVie unveiled a $195 million investment to expand active pharmaceutical ingredient manufacturing in the U.S. Bloomberg reported that BlinkRx, a company that has Donald Trump Jr. on its board, just ...
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President ...
Detailed price information for Dynavax Technologies (DVAX-Q) from The Globe and Mail including charting and trades.
Amid pressure from the White House, U.S. drug companies are experimenting with direct-to-consumer sales models that cut out the middlemen.
The Task Force on Safer Childhood Vaccines returns to oversee vaccine safety, reduce side effects, and enhance reporting.
Among children with eosinophilic asthma receiving mepolizumab who had an exacerbation during an acute respiratory illness, ...